Customer Segmentation Does Not Work What's Wrong With It?

Similar documents
For pharmaceutical and medical products

DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE

Shifting Pharma Sales Models. Text for a pull out can go heretext for a pull out can go heretext for a pull out can go

Best Practices for Program Success. Solutions at the Shelf from Rx EDGE. Rx EDGE. Pharmacy Networks. Media That Delivers

Physician Marketing & Outreach Growing Referring Physician Lifetime Value

YASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA.

BearingPoint Process Advisory

Foodservice Category Management. Better Insights. Enhanced Collaboration. Maximum ROI

A High-Touch Approach to Improving Patient Access. Using field support to navigate reimbursement challenges

New Cardinal Health (Post-Spin)

Santen Acquisition of InnFocus, Developer of MicroShunt Glaucoma Implant Device

INSIDE EMPLOYEES MINDSTM

Message Mapping: Creating a Communications Roadmap

REFERENCE CODE GDHC1106CFR PUBLICATION DATE M AY 2013

How to Make Your Drug Launch a Success

Jordi Aparici Market Intelligence Consultant

DAMA Chicago April 15, 2015 Ken Rabolt

STATE OF THE ASIA-PACIFIC PHARMACEUTICAL INDUSTRY 2013: EXECUTIVE SUMMARY

REFERENCE CODE GDHC1180DFR PUBLICATION DATE M AY 2013

CRM and the Future of Healthcare Engagement

WHITE PAPER. Engaging the Evolving Stakeholder Network: A New Approach for Medical Affairs

Inflation Near 10% Drug Price Growth Nearly Flat at 0.2%

Capital Market Day June 12, 2012

Trinity ConTRact: Cornerstone Projects in Contracting Strategy

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Emerging Pharmaceutical Market - Indonesia and the Philippines -Introduction 3 Emerging

Two Definitions of Market

SEGMENTATION BENEFITS OF SEGMENTATION

A spec i a l r e p o r t w ri t t e n i n a s s o c i at i o n w i t h I M S

M3, Inc. Presentation Material. July Copyright 2017 M3, Inc. All rights reserved.

Workshop on Access to and Uptake of Biosimilar Medicinal Products

Cardinal Health overview and strategic priorities

About DRG Consulting 1

Achieving customer intimacy with IBM SPSS products

ZS Medical Affairs Outlook Report Analysis of Field Medical Growth and Industry Trends

Challenges and Opportunities in Pharma: Perspective for an Emerging Middle East April 24th, 2015

Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS

HEALTHCARE DASHBOARDS

Walgreens Rx Supply Chain Transforming to an Outsource Model

How to enable revenue growth in the digital age

Differentiators that Make a Difference

Aligning internal teams to secure buy-in from external stakeholders: a critical part of launch strategy

INVOLVE KEY STAKEHOLDERS FROM THE START

Control Costs and Increase Employee Engagement With Consumer Advantage

Marketing*Fundamentals!

BIOTECH, MED DEVICE & PHARMA

HCS-Overview Partner Cloud Acceleration. Accelerating Ingram Partners Into The Cloud OPERATIONS 101 Webcast #2

Market Segmentation Seminar

BSI Recruitment Opportunity. October Job Description. Training Insight Sales Executive. Page 1 of 5

FOCUS REIMBURSEMENT STRATEGY TO DEMONSTRATE FULL VALUE STORY

Decoding Phase II Clinical Trial Terminations

How to Make IT the Underpinning of the Enterprise Strategy

Training Plan Small & Medium Enterprises Package Small & Medium Enterprises Certificates

Strategic Capital and Business Alliance Between Fujifilm, Taisho Pharmaceutical and Toyama Chemical

THE CUSTOMER EXPANSION PLAYBOOK. Strategies for maximizing customer lifetime value through cross-sell and upsell

Put Money Back in Your Classroom Finding the hidden revenue in your pharmacy benefits

January (San Francisco, CA) January 8, 2018

2013 North American M2M Communications Competitive Strategy Leadership Award

Johnson & Johnson s trusted and experienced guide. to patient adherence and acquisition

The Role of the Pharmacist in Pharmacovigilance A Regulatory Perspective

AN UNCOMMON SENSE OF THE CONSUMER. Nurturing Innovation: HOW TO SUCCEED IN YEARS TWO AND THREE

Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center

Doctors to Pharma: Let s Get Personalized

Pharmamarketing - strategic challenges

Generate Leads and Drive Sales

ASSISTANCE AND ASSESSMENT:

A Roadmap to Success: Five Guiding Principles to Incentive Compensation Planning. KMK Consulting, Inc.

White paper The Polish pharmaceutical market has undergone many changes as a result of the new Reimbursement Act

Breaking the Silo Mentality Working With Opinion Leaders

Solution Overview. Transform your life and annuities business

Operationalizing NPS Benchmarks. How to Use Comparative Data to Drive Customer Experience Success

IMPULSE CONSULTING Ltd

2018 Senior Living Study. Beyond Measure jdpower.com

Healthcare Payers: In Pursuit of Four Digital Objectives

Mergers & Acquisitions Handbook for Retail Bank Marketers

Tailored Learning Solutions. Measurable Results. Raytheon Professional Services

Policy Administration Transformation

econsult considerations for implementation in California s healthcare safety net

Infectious Disease. Results 18:1. Campaign Objective. Media Plan. Measuring ROI

Brazil Gastric Balloon Procedures Outlook to 2020

Sponsor/CRO Partnership Optimization

CRO partner in Rx/CDx Co-Development

ENABLE INJECTIONS AND FLEX SET AMBITIOUS PLANS FOR LARGE VOLUME DRUG DELIVERY

Targeting & Segmentation

SAMPLE. Mexico Orthopedic Prosthetics Market Outlook to Reference Code: GDMECC0156DB. Publication Date: February 2014

Joyce Mullen. Our Commitment to You. Joyce Mullen. President, Global Channels, OEM Solutions and IoT

Investor Update. Jefferies Global Healthcare Conference June Because people depend on us

MORE OF WHAT MATTERS. Update: UnitedHealthcare Pharmacy Benefit Transition. February 26, 2013

An integrated model approach to improve the management of marketed products

19 th Annual Health & Wellness in America

Embarking on the Journey to Customer Centricity

Product Line Strategy, Dynamic Publishing Solutions Global, Frost & Sullivan s Global Research Platform

DETAILED CONTENTS. Preface... Acknowledgments... Coastal Medical Center Comprehensive Case Study...

DRUG DEVELOPMENT TARGET PRODUCT PROFILE

LexisNexis Health Care data delivered within PlayMaker CRM sales platform

Strategic Planning & Marketing. Eric N. Berkowitz, PhD

SEVEN FEATURED PEGA CASE STUDIES. Different needs, different industries, tailored solutions leveraging Pega solutions

GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE)

How to become a CLTV aligned organization?

Modernizing the Food and Drugs Act to Accommodate a Product Lifecycle Approach

Transcription:

Customer Segmentation Does Not Work What's Wrong With It? July 2017

OSG at a Glance Offices in US, EU and Asia Over 700 projects Diverse range of leading Fortune 500 clients Reference-able C-Suite level relationships at clients across industry sub-sectors Pharmaceuticals, Healthcare, CPG, Energy Recognized analytics thought leader featured in leading publications Recognized for five consecutive years as one of the fastest growing companies in the US 2

OSG s Capabilities in Life Sciences LIFE CYCLE RELATIONSHIP USING TECHNOLOGY & SERVICES COMPETENCIES BUSINESS APPLICATIONS MARKET RESEARCH ADVANCED ANALYTICS ADVISORY TECHNOLOGY R&D/INNOVATION Innovation Prioritization / Market Map Trial Optimization PRO Analytics Portfolio Prioritization DEVELOPMENT Market/Commercial Assessment Licensing & Acquisition Forecasting & Evaluation MARKETING Segmentation Launch Planning Brand Equity & Tracking Brand & LCM Planning Positioning,Message Testing SALES Sales Force Effectiveness Field Optimization Performance Analytics Closed loop Marketing PLATFORMS ASEMAP TM In-Depth Behavioral Analytics Platform OSMPS Online Data Visualization and Predictive Analytics Portal CAVII Customer Engagement Platform 3

What is Segmentation? Different customers have different characteristics Customers with similar characteristics likely Make product choices similarly Respond similarly to promotional efforts 4

Some Challenges with Current Healthcare Segmentations Primarily based on specialty and past Rx volume deciles What drives Rx behavior is not clearly known Message delivered may not resonate as it may not be aligned with true motivation for their behavior 5

OSG s Segmentation is Based on What Matters To Customers DEMOGRAPHIC SEGMENTATION ATTITUDINAL SEGMENTATION LOCATION TRADITIONALISTS AGE VOLUME Easy to target but provides little insight about what customers value EARLY ADOPTERS OVER ACHIEVERS Difficult to target or track performance as attitudes may change over time OSG-SEGMENTTM (Needs and Outcomes Based) ENDURANCE S SIMPLICITY S SAFETY S RAPID TREATERS Provides powerful guidance on how to change behavior and guide strategy/tactics 6

Pharma Example Competitive Psoriasis Market Situation New biologic (Product X) for moderate-to-severe plaque psoriasis Crowded therapeutic area with many established biologics Client (Company X) was seeking an effective way to enter and establish their product in this crowded market OSG s Solution: OSG-Segment OSG recommended using its proprietary ASEMAP TM methodology to develop actionable needs-based segments that can guide effective targeting and messaging for Product X 7

Segmentation Was the First Step in a Fact-Based and Differentiating Go-To-Market Strategy REACHING SEGMENTS & MESSAGING How must Company X convey its value to win in a segment? TARGETING Which customers should Company X focus and align the business around? SEGMENTATION Are there distinct segments of customers that value certain attributes uniquely over other customers? 8

Research Approach 30 minute online survey across 7 countries Screener (2 mins) Usage/Prescription Behavior & TPP Receptivity (5 mins) ASEMAP TM Attributes trade-off exercise (15 mins) ~30 ATTRIBUTES THAT ENCOMPASSED EFFICACY, SAFETY, DOSING, MOA ETC. Attitudes (5 mins) Firmographics (3 mins) 9

ASEMAP Steps in Prioritizing Attributes A. CATEGORIZE ATTRIBUTES B. RANK ATTRIBUTES TM TM C. TRADE OFF ATTRIBUTES TM 10

An ASEMAP Segmentation Is Based on Key Attributes That Drive Choice DERMATOLOGISTS SEGMENTATION EXAMPLE SEGMENT 1 SEGMENT 2 SEGMENT 3 SEGMENT 4 Availability of long-term safety data 250 117 120 115 Percent of patients who achieved PASI 100 at week 12 120 120 185 110 Percent of patients reporting PASI 75 at week 12 who achieved PASI 90 at week 52 120 200 115 100 Incidence of malignancies 215 105 105 98 Percent of patients who achieved PASI 90 at week 12 110 115 180 100 Percent of patients who achieved PASI 75 at week 12 110 110 130 115 Incidence of serious infections 200 105 105 105 Incidence of nausea 150 95 95 175 Incidence of vomiting 130 95 90 150 Ability of patients to return to work 100 90 85 155 EMPHASIS ON SERIOUSSAFETY ISSUES EMPHASIS ON ENDURANCE EMPHASIS ON RAPID OR SHORT-TERM EFFICACY EMPHASIS ON SIDE-EFFECTSAND PRACTICAL PATIENT OUTCOMES 11

Combining Attributes Importance with Attitudes & Behavior for Holistic Segmentation Points of differentiation DERMATOLOGISTS SEGMENTATION EXAMPLE Segment 1 Segment 2 Segment 3 Segment 4 Differentiating Attribute Categories Serious safety issues Endurance Rapid Efficacy Side-effects & Patient outcomes Key Attitudes Try out new treatments only after they have been in the market for a long period Top priority is to improve clinical outcomes Keep up with breaking developments in the field Priority is to improve profitability, physician and employee satisfaction First to try new treatments Fear of side-effects limits their prescription of biologics Burdened by administrative paperwork Treat patients aggressively More likely to discuss patient support programs Prescribing Behavior Lowest biologic prescribers High biologic prescribers High biologic prescribers Have a wider prescription pattern (biologics, topicals, systemics, light therapy, orals) Firmographics Primarily a medical practice Primarily a medical practice Primarily a cosmetic practice Mix of medical and cosmetic practice SAFETY ENDURANCE RAPID TREATER SIMPLICITY 12

Develop Actionable Segment Personalities Segment Personalities & Messaging Attributes Attitudes Usage Behavior & Demographics 13

A Fact-Based Approach Must be Taken for Identifying Target Segments REACHING SEGMENTS & MESSAGING How must Company X convey its value to win in a segment? TARGETING Which customers should Company X focus and align the business around? SEGMENTATION Are there distinct segments of customers that value certain attributes uniquely over other customers? 14

The Highest Priority Segments Were identified Through An Exhaustive Fact-Based Process SAFETY ENDURANCE RAPID TREATER ENDURANCE SAFETY SIMPLICITY PRIMARY TARGETS SIMPLICITY Example Criteria for Segment Targeting RAPID TREATER SECONDARY TARGET Can Product X demonstrate superiority vs. competition on attributes that uniquely matter to this segment? Is this segment sizeable enough to justify the effort? How much effort would it take to acquire customers in this segment? 15

Communication Must be Tailored Towards Segments for Greater Impact REACHING SEGMENTS & MESSAGING How must Company X convey its value to win in a segment? TARGETING Which customers should Company X focus and align the business around? SEGMENTATION Are there distinct segments of customers that value certain attributes uniquely over other customers? 16

Empowered Sales Team With A Targeted Product Selling Toolkit ENDURANCE SAFETY OSG worked with Company X and an agency to develop and prioritize the right messages, visual aids and other marketing collateral Segment Tool Kits (Segment Profiles and Insights, Messaging Platforms, E-detailing, Visual aids and Enablers to Selling) SIMPLICITY 17

Developed an easy-to-use tablet/mobile based typing tool that Integrated with Company s IT System for Classification and Identification TYPING TOOL (Administered via sales reps, online surveys or using secondary data) Hello Dr. John, can you please review these 8 statements and rank them for me? It will take 15 seconds. I am just trying to understand what is important to you in choosing a treatment for plaque psoriasis. TYPING TOOL CLASSIFICATION BROAD DIRECTIONS TO SALES REP ON COMMUNICATING THE PRODUCT S VALUE PROPOSITION 18

Impact of OSG s Segmentation Product Impact Improvement in market share in crowded categories Faster uptake of new products Organizational Impact Sales Streamlined sales activities to target key segments and improved sales calls and prospects Improved the velocity of opportunities Decreased cost to serve Marketing Elevated the relevance of the marketing as a key enabler of success to the business R&D Entire R&D portfolio was aligned to the needs of key customer segments Implemented as a first screen to understand how to assess the potential of new technology 19

OSG Advantage: Why OSG for Segmentation? I. Unique Segmentation Approach OSG uses a combination of needs (ASEMAP TM ), attitudes, behaviors and demographics to develop a holistic segmentation II. Long-term Applicability OSG segments hold longterm relevance without the need for periodic refresh because it is based on customer current and future needs III. Proven Across Verticals OSG has successfully executed segmentations across multiple verticals (Pharma (multiple therapeutic areas), Medical devices, CPGetc.) IV. One Stop-Shop for Developing & Activating Segments OSG s teams combine analytical rigor (various approaches to develop segments such as K- means, Latent class, Hierarchical clustering etc.) with practical know-how to develop actionable and targetable segments V. Developing Segmentation Toolkits OSG s project and graphics teams have combined to develop segment toolkits for clients for company-wide socialization (i.e. segment booklets, segment pocketbooks etc.) 20

Contacts Mani Vannan, PhD E. Mani.Vannan@optimalstrategix.com M.+1 9174284396 O.+1 2128979960 Sanjeev R Sridharan E. Sanjeev.Sridharan@optimalstrategix.com M.+1 2158671924 O.+1 4692586949 WWW.OSGANALYTICS.COM